Louveau, B., lebbe, c., & Mourah, S. (2019). Baseline Genomic Features in BRAFV600-Mutated Metastatic Melanoma Patients Treated with BRAF Inhibitor + MEK Inhibitor in Routine Care - DATASET. Zenodo.
Cita Chicago Style (17a ed.)Louveau, Baptiste, celeste lebbe, y Samia Mourah. Baseline Genomic Features in BRAFV600-Mutated Metastatic Melanoma Patients Treated with BRAF Inhibitor + MEK Inhibitor in Routine Care - DATASET. Zenodo, 2019.
Cita MLA (9a ed.)Louveau, Baptiste, et al. Baseline Genomic Features in BRAFV600-Mutated Metastatic Melanoma Patients Treated with BRAF Inhibitor + MEK Inhibitor in Routine Care - DATASET. Zenodo, 2019.
Precaución: Estas citas no son 100% exactas.